The survey results reveal strong enthusiasm for blood-based screening options among adults aged 45 and older, the group ...
Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted the survey from Feb. 24-26, 2026, among 1,189 U.S. adults, ages 45 and ...
AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics™, a science-first, health care technology company, today announced that a key piece of its BetterWay™ Blood Testing ecosystem has achieved 510(k) ...
With the approval of anti-amyloid monoclonal antibodies to treat early-stage Alzheimer’s disease (AD), the need for accurate and early diagnosis is crucial. Blood-based biomarkers offer a promising ...
Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
A team led by La Trobe University has drawn inspiration from nature to develop a breakthrough sensor that can rapidly track ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results